Abivax ABVX
NASDAQ ABVX
$96.85 +5.79 (+6.36%)
At close: Sep 28, 2026 · 4:00 PM EDT

Abivax (ABVX) Shares Outstanding (Entity) (2021 - 2025)

Updated

Abivax (ABVX) reported Shares Outstanding (Entity) of 78.54 million for Q4 2025, up 24.0% from 63.35 million a year earlier.

Analysis

Abivax (ABVX) Shares Outstanding (Entity) (2021 - 2025) Analysis & Trends

Dating back to Q4 2021, Abivax's Shares Outstanding (Entity) record includes 5 quarters.

  • Shares Outstanding (Entity) has increased for four consecutive years, with a four-year compound annual growth rate of 47.1% (FY2021 to FY2025).
  • By year, Shares Outstanding (Entity) came in at 63.35 million in FY2024 (+47.1%), 43.07 million in FY2023 (+93.1%), 22.3 million in FY2022 (+33.1%) and 16.76 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 2.41 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 1.77 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 1.24 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 253.35 Mn
10 Abivax 7.15 Bn 7.15 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 78.54 Mn
Dec 31, 2024 63.35 Mn
Dec 31, 2023 43.07 Mn
Dec 31, 2022 22.30 Mn
Dec 31, 2021 16.76 Mn
API Access

Abivax Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ABVX&period=max&api_key=YOUR_API_KEY